JP2020528891A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020528891A5 JP2020528891A5 JP2020503266A JP2020503266A JP2020528891A5 JP 2020528891 A5 JP2020528891 A5 JP 2020528891A5 JP 2020503266 A JP2020503266 A JP 2020503266A JP 2020503266 A JP2020503266 A JP 2020503266A JP 2020528891 A5 JP2020528891 A5 JP 2020528891A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- tca cycle
- prodrugs
- compound according
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims description 77
- 239000000651 prodrug Substances 0.000 claims description 52
- 229940002612 prodrugs Drugs 0.000 claims description 52
- 230000004102 tricarboxylic acid cycle Effects 0.000 claims description 51
- 239000000203 mixture Substances 0.000 claims description 47
- 239000000543 intermediate Substances 0.000 claims description 46
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 40
- 235000001014 amino acid Nutrition 0.000 claims description 38
- 150000001413 amino acids Chemical class 0.000 claims description 38
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 25
- 229940086735 succinate Drugs 0.000 claims description 24
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 claims description 24
- 235000004400 serine Nutrition 0.000 claims description 23
- 229920005862 polyol Polymers 0.000 claims description 20
- 150000003077 polyols Chemical class 0.000 claims description 20
- KRKNYBCHXYNGOX-UHFFFAOYSA-K 2qpq Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 18
- 229940049920 malate Drugs 0.000 claims description 14
- BJEPYKJPYRNKOW-UHFFFAOYSA-L malate(2-) Chemical compound [O-]C(=O)C(O)CC([O-])=O BJEPYKJPYRNKOW-UHFFFAOYSA-L 0.000 claims description 14
- MTCFGRXMJLQNBG-UWTATZPHSA-N D-serine Chemical compound OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 claims description 13
- 230000036740 Metabolism Effects 0.000 claims description 11
- 230000004060 metabolic process Effects 0.000 claims description 11
- 230000035786 metabolism Effects 0.000 claims description 11
- KPGXRSRHYNQIFN-UHFFFAOYSA-L 2-oxoglutarate(2-) Chemical compound [O-]C(=O)CCC(=O)C([O-])=O KPGXRSRHYNQIFN-UHFFFAOYSA-L 0.000 claims description 10
- REKYPYSUBKSCAT-UHFFFAOYSA-N 3-Hydroxypentanoic acid Chemical compound CCC(O)CC(O)=O REKYPYSUBKSCAT-UHFFFAOYSA-N 0.000 claims description 9
- ODBLHEXUDAPZAU-ZAFYKAAXSA-K D-threo-isocitrate(3-) Chemical compound [O-]C(=O)[C@H](O)[C@@H](C([O-])=O)CC([O-])=O ODBLHEXUDAPZAU-ZAFYKAAXSA-K 0.000 claims description 9
- KHPXUQMNIQBQEV-UHFFFAOYSA-M Oxaloacetate Ion Chemical compound OC(=O)C(=O)CC([O-])=O KHPXUQMNIQBQEV-UHFFFAOYSA-M 0.000 claims description 9
- 229940076788 Pyruvate Drugs 0.000 claims description 9
- 229940050411 fumarate Drugs 0.000 claims description 9
- VZCYOOQTPOCHFL-UHFFFAOYSA-N fumaric acid Chemical compound OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 9
- LCTONWCANYUPML-UHFFFAOYSA-M pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 claims description 9
- WDJHALXBUFZDSR-UHFFFAOYSA-M acetoacetate Chemical compound CC(=O)CC([O-])=O WDJHALXBUFZDSR-UHFFFAOYSA-M 0.000 claims description 8
- GTZCVFVGUGFEME-IWQZZHSRSA-K cis-aconitate(3-) Chemical compound [O-]C(=O)C\C(C([O-])=O)=C\C([O-])=O GTZCVFVGUGFEME-IWQZZHSRSA-K 0.000 claims description 8
- FHSUFDYFOHSYHI-UHFFFAOYSA-N 3-Oxopentanoic acid Chemical compound CCC(=O)CC(O)=O FHSUFDYFOHSYHI-UHFFFAOYSA-N 0.000 claims description 6
- 125000003607 serino group Chemical group [H]OC(=O)C([H])(N([H])*)C([H])([H])O[H] 0.000 claims description 6
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 4
- 150000003355 serines Chemical class 0.000 claims description 4
- 150000003890 succinate salts Chemical class 0.000 claims description 4
- 125000004430 oxygen atoms Chemical group O* 0.000 claims description 3
- -1 cis-aconite Chemical compound 0.000 claims 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 22
- 201000010099 disease Diseases 0.000 description 18
- 229960004106 citric acid Drugs 0.000 description 11
- 150000003839 salts Chemical class 0.000 description 9
- 239000011780 sodium chloride Substances 0.000 description 9
- WHBMMWSBFZVSSR-UHFFFAOYSA-M 3-hydroxybutyrate Chemical compound CC(O)CC([O-])=O WHBMMWSBFZVSSR-UHFFFAOYSA-M 0.000 description 6
- 229960004543 Anhydrous Citric Acid Drugs 0.000 description 6
- 208000008425 Protein Deficiency Diseases 0.000 description 6
- 150000008064 anhydrides Chemical class 0.000 description 6
- 201000003694 methylmalonic acidemia Diseases 0.000 description 6
- 230000002438 mitochondrial Effects 0.000 description 6
- 201000004012 propionic acidemia Diseases 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 5
- 208000010444 Acidosis Diseases 0.000 description 3
- 0 CC(*COC(CCC(OCC(COC(CCC(N=C[C@@](C(O)=O)N)=N)=O)NC(CCC(OC[C@](*)C(O)=O)=*)=O)=*)=*)N=C Chemical compound CC(*COC(CCC(OCC(COC(CCC(N=C[C@@](C(O)=O)N)=N)=O)NC(CCC(OC[C@](*)C(O)=O)=*)=O)=*)=*)N=C 0.000 description 3
- 208000001654 Drug Resistant Epilepsy Diseases 0.000 description 3
- 206010015037 Epilepsy Diseases 0.000 description 3
- 206010016256 Fatigue Diseases 0.000 description 3
- 208000005461 Glutaric Acidemia I Diseases 0.000 description 3
- 206010061205 Hereditary disease Diseases 0.000 description 3
- 102000004317 Lyases Human genes 0.000 description 3
- 108090000856 Lyases Proteins 0.000 description 3
- 208000009564 MELAS Syndrome Diseases 0.000 description 3
- 208000005894 Mitochondrial Myopathy Diseases 0.000 description 3
- 208000003627 Muscular Dystrophy Diseases 0.000 description 3
- 206010053643 Neurodegenerative disease Diseases 0.000 description 3
- 102100017629 POLG Human genes 0.000 description 3
- 101700012117 POLG Proteins 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 208000010337 Pyruvate Carboxylase Deficiency Disease Diseases 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 150000004668 long chain fatty acids Chemical class 0.000 description 3
- 201000002169 mitochondrial myopathy Diseases 0.000 description 3
- 201000003645 multiple acyl-CoA dehydrogenase deficiency Diseases 0.000 description 3
- 201000006938 muscular dystrophy Diseases 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 230000000926 neurological Effects 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 230000035806 respiratory chain Effects 0.000 description 3
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- 230000002496 gastric Effects 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 1
- 229960001230 Asparagine Drugs 0.000 description 1
- 229960005261 Aspartic Acid Drugs 0.000 description 1
- LSMCBOCQMLTGBW-UHFFFAOYSA-N CCC(COC(C(CC(O)OC)(CC(OC(C)C)=O)[O]=C)=O)[O]=[O](C(CC(C)O)(CC(OCC(CO)OC)=C1CC1)C(OCC(CNC)[O]=C)=O)=C Chemical compound CCC(COC(C(CC(O)OC)(CC(OC(C)C)=O)[O]=C)=O)[O]=[O](C(CC(C)O)(CC(OCC(CO)OC)=C1CC1)C(OCC(CNC)[O]=C)=O)=C LSMCBOCQMLTGBW-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 description 1
- 229960002989 Glutamic Acid Drugs 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229960000310 ISOLEUCINE Drugs 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229960005190 Phenylalanine Drugs 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atoms Chemical group C* 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
Description
åçç©
æ¬æ现æžã«é瀺ããã³èª¬æãããã®ã«å ããŠãæ¬çºæã®çš®ã ã®æ¹å€ããã³ãããªãå€æ°ã®å®æœåœ¢æ ããæ¬æ现æžã§å ·äœçã«åŒçšããç§åŠçæç®ããã³ç¹èš±æç®ãžã®åç §ãå«ãæ¬æ现æžã®å å®¹å šäœãããåœæ¥è ã«æããã«ãªãã§ããããããã§ã®äž»é¡ã¯ãæ¬çºæã®çš®ã ã®å®æœåœ¢æ ããã³ãã®åçç©ã®å®æœã«é©åããåŸããéèŠãªæ å ±ãäŸç€ºãããã³ã¬ã€ãã³ã¹ãå«ãã§ããã
æ¬çºæã¯ãäŸãã°ä»¥äžã®é ç®ãæäŸããã
ïŒé ç®ïŒïŒ
ïŒã€ãŸãã¯ãããè¶ ããåè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ãšã
ïŒã€ãŸãã¯ãããè¶ ããã¢ããé žãš
ãå«ããååç©ã
ïŒé ç®ïŒïŒ
åèšååç©ãã
äºãã«ååŠçã«çµåããïŒã€ãŸãã¯ãããè¶ ããåè·¯äžéäœãããã¯ãã®ãããã©ãã°ãšã
ïŒã€ãŸãã¯ãããè¶ ããã¢ããé žãš
ãå«ããé ç®ïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããåè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããã·ãã¬ãŒããïœïœïœâã¢ã³ãããŒããâã€ãœã·ãã¬ãŒããαâã±ãã°ã«ã¿ã¬ãŒããã¹ã¯ã·ããŒããããã¬ãŒãããã¬ãŒãããªããµãã¢ã»ããŒãããã«ããŒããã¢ã»ãã³ãã¢ã»ãã¢ã»ããŒããβâããããã·ããã¬ãŒããβâã±ããã³ã¿ããšãŒããããã³Î²âããããã·ãã³ã¿ããšãŒããããªã矀ããéžæããããé ç®ïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããåè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããã¹ã¯ã·ããŒãã§ãããé ç®ïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããåŒïŒïŒ©ïŒãïŒïŒ©ïŒ©ïŒãïŒïŒ©ïŒ©ïŒ©ïŒãïŒïŒ©ïŒ¶ïŒãããã³ïŒïŒ¶ïŒïŒ
âβâããããã·ããã¬ãŒãââβâããããã·ããã¬ãŒãâïŒïŒ©ïŒ¶ïŒãããã³
ââïŒïŒ¶ïŒ
ãããªã矀ããéžæãããåŒã§è¡šãããåŒäžã
ã¯ãã»ãªã³ã§ããïŒ
ã¯ãã¹ã¯ã·ããŒãã§ããïŒ
ã¯ããã¬ãŒãã§ããïŒ
ã¯ãã¹ã¯ã·ããŒãã§ããïŒãã€
ã¯ãã»ãªã³ã§ããã
é ç®ïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããã¢ããé žããã»ãªã³ããã³ããã·ã³ãããªã矀ããéžæããããé ç®ïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããã¢ããé žããã»ãªã³ã§ãããé ç®ïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããäžéäœãããã¯ãã®ãããã©ãã°ããããªãªãŒã«ãä»ããŠçµåããŠãããé ç®ïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒ
åèšããªãªãŒã«ããã°ãªã»ããŒã«ã§ãããé ç®ïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšååç©ããåŒïŒïŒ¶ïŒ©ïŒïŒ
ã§è¡šãããåŒäžã
 ïŒ ã ïŒ ãããã³ïŒ² ïŒ ããã¹ã¯ã·ããŒãã§ããïŒ
 ïŒ ã ïŒ ãããã³ïŒ² ïŒ ããã»ãªã³ã§ããïŒãã€
 ïŒ ã ïŒ ãããã³ïŒ² ïŒ ãããããã®åŽéäžã®é žçŽ ååãä»ããŠããããã ïŒ ã ïŒ ãããã³ïŒ² ïŒ ãšçµåããŠããã
é ç®ïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
ïŒã€ãŸãã¯ãããè¶ ããåè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ãšïŒ
ïŒã€ãŸãã¯ãããè¶ ããã¢ããé žãš
ãå«ãååç©ãã被éšäœã«æäŸããããšãå«ããåèšè¢«éšäœã«ãããå€åããå路代è¬ã«é¢é£ããç¶æ ãåŠçœ®ããæ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšååç©ãã
äºãã«ååŠçã«çµåããïŒã€ãŸãã¯ãããè¶ ããåè·¯äžéäœãããã¯ãã®ãããã©ãã°ãšïŒ
ïŒã€ãŸãã¯ãããè¶ ããã¢ããé žãš
ãå«ããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããåè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããã·ãã¬ãŒããïœïœïœâã¢ã³ãããŒããâã€ãœã·ãã¬ãŒããαâã±ãã°ã«ã¿ã¬ãŒããã¹ã¯ã·ããŒããããã¬ãŒãããã¬ãŒãããªããµãã¢ã»ããŒãããã«ããŒããã¢ã»ãã³ãã¢ã»ãã¢ã»ããŒããβâããããã·ããã¬ãŒããβâã±ããã³ã¿ããšãŒããããã³Î²âããããã·ãã³ã¿ããšãŒããããªã矀ããéžæããããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããåè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããã¹ã¯ã·ããŒãã§ãããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããåŒïŒïŒ©ïŒãïŒïŒ©ïŒ©ïŒãïŒïŒ©ïŒ©ïŒ©ïŒãïŒïŒ©ïŒ¶ïŒãããã³ïŒïŒ¶ïŒïŒ
âβâããããã·ããã¬ãŒãââβâããããã·ããã¬ãŒãâïŒïŒ©ïŒ¶ïŒãããã³
ââïŒïŒ¶ïŒ
ãããªã矀ããéžæãããåŒã§è¡šãããåŒäžã
ã¯ãã»ãªã³ã§ããïŒ
ã¯ãã¹ã¯ã·ããŒãã§ããïŒ
ã¯ããã¬ãŒãã§ããïŒ
ã¯ãã¹ã¯ã·ããŒãã§ããïŒãã€
ã¯ãã»ãªã³ã§ããã
é ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããã¢ããé žããã»ãªã³ããã³ããã·ã³ãããªã矀ããéžæããããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããã¢ããé žããã»ãªã³ã§ãããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããäžéäœãããã¯ãã®ãããã©ãã°ããããªãªãŒã«ãä»ããŠçµåããŠãããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšããªãªãŒã«ããã°ãªã»ããŒã«ã§ãããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšååç©ããåŒïŒïŒ¶ïŒ©ïŒïŒ
ã§è¡šãããåŒäžã
 ïŒ ã ïŒ ãããã³ïŒ² ïŒ ããã¹ã¯ã·ããŒãã§ããïŒ
 ïŒ ã ïŒ ãããã³ïŒ² ïŒ ããã»ãªã³ã§ããïŒãã€
 ïŒ ã ïŒ ãããã³ïŒ² ïŒ ãããããã®åŽéäžã®é žçŽ ååãä»ããŠããããã ïŒ ã ïŒ ãããã³ïŒ² ïŒ ãšçµåããŠããã
é ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
第ïŒã®ïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ãšïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ã«å ±æçµåããïŒã€ãŸãã¯ãããè¶ ãããã£ããã³ã°éšåãš
ãå«ããååç©ã
ïŒé ç®ïŒïŒïŒ
åãã£ããã³ã°éšåããç¬ç«ããŠããªãªãŒã«ãããªã矀ããéžæããããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããã·ãã¬ãŒããïœïœïœâã¢ã³ãããŒããâã€ãœã·ãã¬ãŒããαâã±ãã°ã«ã¿ã¬ãŒããã¹ã¯ã·ããŒããããã¬ãŒãããã¬ãŒãããªããµãã¢ã»ããŒãããã«ããŒããã¢ã»ãã³ãã¢ã»ãã¢ã»ããŒããβâããããã·ããã¬ãŒããβâã±ããã³ã¿ããšãŒããããã³Î²âããããã·ãã³ã¿ããšãŒããããªã矀ããéžæããããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããã¹ã¯ã·ããŒãã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ãããã£ããã³ã°éšåããã°ãªã»ããŒã«ã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
ååç©ããåèšã¹ã¯ã·ããŒãäžã®æ«ç«¯ççŽ ååãä»ããŠå ±æçµåããïŒã€ã®ã°ãªã»ããŒã«éšåãå«ããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšååç©ããåŒïŒïŒ¶ïŒ©ïŒ©ïŒãïŒïŒ¶ïŒ©ïŒ©ïŒ©ïŒãããã³ïŒïŒ©ïŒžïŒïŒ
ããéžæãããåŒã§è¡šããããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
第ïŒã®ãã£ããã³ã°éšåããã¢ããé žã§ããïŒ
第ïŒã®ãã£ããã³ã°éšåãã第ïŒã®ïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšç¬¬ïŒã®ïŒŽïŒ£ïŒ¡åè·¯äžéäœããã¹ã¯ã·ããŒãã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšç¬¬ïŒã®ãã£ããã³ã°éšåããã»ãªã³ã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšç¬¬ïŒã®ãã£ããã³ã°éšåãããã¬ãŒãã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšååç©ããåŒïŒïŒžïŒïŒ
ã§è¡šããããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
ããªãªãŒã«ãšïŒ
åèšããªãªãŒã«ã«å ±æçµåããåè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ãšïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ã«å ±æçµåããã¢ããé žãš
ãå«ããååç©ã
ïŒé ç®ïŒïŒïŒ
åèšããªãªãŒã«ããã°ãªã»ããŒã«ã§ããïŒ
åèšå ±æçµåããïŒïœïœïœïœïœïœ ïœïœïœïœïŒïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããã¹ã¯ã·ããŒãã§ããïŒ
åèšã¢ããé žããã»ãªã³ã§ããã
é ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšååç©ããåŒïŒïŒžïŒ©ïŒ©ïŒ©ïŒïŒ
ã§è¡šããããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšååç©ããåŒïŒïŒžïŒ©ïŒ¶ïŒïŒ
ã§è¡šããããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœããαâã±ãã°ã«ã¿ã¬ãŒãã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšã¢ããé žããã»ãªã³ã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšããªãªãŒã«ããã°ãªã»ããŒã«ã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšååç©ããåŒïŒïŒžïŒ¶ïŒïŒ
ã§è¡šããããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœããβâããããã·ããã¬ãŒãã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšã¢ããé žããã»ãªã³ã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšããªãªãŒã«ããã°ãªã»ããŒã«ã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšååç©ããåŒïŒïŒžïŒ¶ïŒ©ïŒïŒ
ã§è¡šããããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
ã·ãã¬ãŒããããã¯ã¯ãšã³é žããŸãã¯ãã®ãããã©ãã°ãã¢ããã°ãèªå°äœããããã¯å¡©ãšïŒ
ïŒã€ãŸãã¯ãããè¶ ããã¢ããé žãš
ãå«ããååç©ã
ïŒé ç®ïŒïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããã¢ããé žã®ãã¡å°ãªããšãïŒã€ã倩ç¶ã«ååšããã¢ããé žã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããã¢ããé žã®å šãŠã倩ç¶ã«ååšããã¢ããé žã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããã¢ããé žããã¢ã©ãã³ãã¢ã«ã®ãã³ãã¢ã¹ãã©ã®ã³ãã¢ã¹ãã©ã®ã³é žãã·ã¹ãã€ã³ãã°ã«ã¿ãã³ãã°ã«ã¿ãã³é žãã°ãªã·ã³ããã¹ããžã³ãã€ãœãã€ã·ã³ããã€ã·ã³ããªãžã³ãã¡ããªãã³ããã§ãã«ã¢ã©ãã³ããããªã³ãã»ãªã³ãã¹ã¬ãªãã³ãããªãããã¡ã³ãããã·ã³ãããªã³ãããã³ãããã®çµã¿åãããããªã矀ããéžæããããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããã¢ããé žã®ãã¡å°ãªããšãïŒã€ãã倩ç¶ã«ååšããªãã¢ããé žã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããã¢ããé žã®å šãŠã倩ç¶ã«ååšããªãã¢ããé žã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããã¢ããé žãã倩ç¶ã«ååšããã¢ããé žãšã倩ç¶ã«ååšããªãã¢ããé žãšã®çµã¿åããã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšååç©ããè€æ°ã®ã¢ããé žãå«ããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšååç©ããïŒã€ã®ã¢ããé žãå«ããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšååç©ããïŒã€ã®ã»ãªã³ãå«ããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšååç©ããåŒïŒïŒžïŒ¶ïŒ©ïŒ©ïŒïŒ
ã§è¡šããããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
被éšäœã«ãããå€åããå路代è¬ã«é¢é£ããç¶æ ãåŠçœ®ããããã®ãæ²»çæå¹éã®ãïŒã€ãŸãã¯ãããè¶ ããããªãªãŒã«ååã«å ±æçµåããå°ãªããšãïŒã€ã®ïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ãå«ããçµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããã·ãã¬ãŒããïœïœïœâã¢ã³ãããŒããâã€ãœã·ãã¬ãŒããαâã±ãã°ã«ã¿ã¬ãŒããã¹ã¯ã·ããŒããããã¬ãŒãããã¬ãŒãããªããµãã¢ã»ããŒãããã«ããŒããã¢ã»ãã³ãã¢ã»ãã¢ã»ããŒããβâããããã·ããã¬ãŒããβâã±ããã³ã¿ããšãŒããããã³Î²âããããã·ãã³ã¿ããšãŒããããªã矀ããéžæããããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããã·ãã¬ãŒãã§ãããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšããªãªãŒã«ããã°ãªã»ããŒã«ã§ãããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšçµæç©ããïŒã€ãŸãã¯ãããè¶ ããã°ãªã»ããŒã«ååã«å ±æçµåãããè€æ°ã®ã·ãã¬ãŒãååãå«ããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšçµæç©ããè€æ°ã®ã·ãã¬ãŒãååãå«ã¿ãåèšè€æ°ã®ã·ãã¬ãŒãååã®ãã¡å°ãªããšãïŒã€ããè€æ°ã®ã°ãªã»ããŒã«ååã«å ±æçµåããŠãããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšçµæç©ããåŒïŒžïŒ¶ïŒ©ïŒ©ïŒ©ïŒ
ã®ååç©ãå«ããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšå€åããå路代è¬ã«é¢é£ããç¶æ ããéºäŒæ§é害ãç¥çµå€æ§é害ãããããšãã«ã®ãŒé害ãé£æ²»æ§ãŠããããããããªã³é žè¡çïŒïŒ°ïŒ¡ïŒãã¡ãã«ããã³é žè¡çïŒïŒïŒïŒ¡ïŒãé·éèèªé žé žåé害ãã¹ã¯ã·ãã«ïŒ£ïœïŒ¡ãªã¢ãŒãŒæ¬ æçããã«ãã³é žã«ã«ããã·ã©ãŒãŒæ¬ æçãããã³ã³ããªã¢åŒåžéäžå šçãã°ã«ã¿ã«é žè¡çïŒåãããã¯ïŒå ç¥çµçŸæ£ãé害ããããã¯ç¶æ ãçŒçãããã¯ç²åŽç ãçãžã¹ãããã£ãŒãããã³ã³ããªã¢ççãé«ä¹³é žè¡çãšè³åäžæ§çç¶ããã€è³ççïŒïŒïŒ¥ïŒ¬ïŒ¡ïŒ³ïŒãèµ€è²ãŒãç·ç¶ã䌎ãããªã¯ããŒãã¹ãŠãããïŒïŒïŒ¥ïŒ²ïŒ²ïŒŠïŒãããã³ã³ããªã¢é¢é£çŸæ£ãããã³ïŒ°ïŒ¯ïŒ¬ïŒ§å€ç°ã«é¢é£ããé害ãããªã矀ããéžæããããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšçµæç©ããçµå£æäžçšã«è£œå€åããããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšçµæç©ããåååäœçšéãšããŠè£œå€åããããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
被éšäœã«ãããå€åããå路代è¬ã«é¢é£ããç¶æ ãåŠçœ®ããããã®ãæ²»çæå¹éã®ãïŒã€ãŸãã¯ãããè¶ ããããªãªãŒã«ååã«å ±æçµåããå°ãªããšãïŒã€ã®ïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ãå«ãçµæç©ãæäŸããããšãå«ããåèšè¢«éšäœã«ãããå€åããå路代è¬ã«é¢é£ããç¶æ ãåŠçœ®ããããã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããã·ãã¬ãŒããïœïœïœâã¢ã³ãããŒããâã€ãœã·ãã¬ãŒããαâã±ãã°ã«ã¿ã¬ãŒããã¹ã¯ã·ããŒããããã¬ãŒãããã¬ãŒãããªããµãã¢ã»ããŒãããã«ããŒããã¢ã»ãã³ãã¢ã»ãã¢ã»ããŒããβâããããã·ããã¬ãŒããβâã±ããã³ã¿ããšãŒããããã³Î²âããããã·ãã³ã¿ããšãŒããããªã矀ããéžæããããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããã·ãã¬ãŒãã§ãããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšããªãªãŒã«ããã°ãªã»ããŒã«ã§ãããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšçµæç©ããïŒã€ãŸãã¯ãããè¶ ããã°ãªã»ããŒã«ååã«å ±æçµåãããè€æ°ã®ã·ãã¬ãŒãååãå«ããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšçµæç©ããè€æ°ã®ã·ãã¬ãŒãååãå«ã¿ãåèšè€æ°ã®ã·ãã¬ãŒãååã®ãã¡å°ãªããšãïŒã€ããè€æ°ã®ã°ãªã»ããŒã«ååã«å ±æçµåããŠãããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšçµæç©ããåŒïŒžïŒ¶ïŒ©ïŒ©ïŒ©ïŒ
ã®ååç©ãå«ããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšå€åããå路代è¬ã«é¢é£ããç¶æ ããéºäŒæ§é害ãç¥çµå€æ§é害ãããããšãã«ã®ãŒé害ãé£æ²»æ§ãŠããããããããªã³é žè¡çïŒïŒ°ïŒ¡ïŒãã¡ãã«ããã³é žè¡çïŒïŒïŒïŒ¡ïŒãé·éèèªé žé žåé害ãã¹ã¯ã·ãã«ïŒ£ïœïŒ¡ãªã¢ãŒãŒæ¬ æçããã«ãã³é žã«ã«ããã·ã©ãŒãŒæ¬ æçãããã³ã³ããªã¢åŒåžéäžå šçãã°ã«ã¿ã«é žè¡çïŒåãããã¯ïŒå ç¥çµçŸæ£ãé害ããããã¯ç¶æ ãçŒçãããã¯ç²åŽç ãçãžã¹ãããã£ãŒãããã³ã³ããªã¢ççãé«ä¹³é žè¡çãšè³åäžæ§çç¶ããã€è³ççïŒïŒïŒ¥ïŒ¬ïŒ¡ïŒ³ïŒãèµ€è²ãŒãç·ç¶ã䌎ãããªã¯ããŒãã¹ãŠãããïŒïŒïŒ¥ïŒ²ïŒ²ïŒŠïŒãããã³ã³ããªã¢é¢é£çŸæ£ãããã³ïŒ°ïŒ¯ïŒ¬ïŒ§å€ç°ã«é¢é£ããé害ãããªã矀ããéžæããããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšçµæç©ããçµå£æäžçšã«è£œå€åããããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšçµæç©ããåååäœçšéãšããŠè£œå€åããããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
被éšäœã«ãããå€åããå路代è¬ã«é¢é£ããç¶æ ãåŠçœ®ããããã®ãæ²»çæå¹éã®ãåè·¯äžéäœç¡æ°Žç©ãããã¯ããªããŒããŸãã¯è¬åŠçã«èš±å®¹ããåŸããã®å¡©ãããã¯ãããã©ãã°ãå«ããçµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœãããã¯ããªããŒããŸãã¯è¬åŠçã«èš±å®¹ããåŸããã®å¡©ãããã¯ãããã©ãã°ããã·ãã¬ãŒããïœïœïœâã¢ã³ãããŒããâã€ãœã·ãã¬ãŒããαâã±ãã°ã«ã¿ã¬ãŒããã¹ã¯ã·ããŒããããã¬ãŒãããã¬ãŒãããªããµãã¢ã»ããŒãããã«ããŒããã¢ã»ãã³ãã¢ã»ãã¢ã»ããŒããβâããããã·ããã¬ãŒããβâã±ããã³ã¿ããšãŒããããã³Î²âããããã·ãã³ã¿ããšãŒããããªã矀ããéžæããããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšãããã©ãã°ããïŒã€ãŸãã¯ãããè¶ ããããªãªãŒã«ãå«ããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšãããã©ãã°ããïŒã€ãŸãã¯ãããè¶ ããã¢ããé žãå«ããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšãããã©ãã°ããïŒã€ãŸãã¯ãããè¶ ããããªãªãŒã«ãšãïŒã€ãŸãã¯ãããè¶ ããã¢ããé žãšãå«ããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœç¡æ°Žç©ãããã¯ããªããŒããŸãã¯è¬åŠçã«èš±å®¹ããåŸããã®å¡©ãããã¯ãããã©ãã°ããç¡æ°Žã¯ãšã³é žãããã¯ããªããŒããŸãã¯è¬åŠçã«èš±å®¹ããåŸããã®å¡©ãããã¯ãããã©ãã°ã§ãããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšç¡æ°Žã¯ãšã³é žãã察称ãªç¡æ°Žã¯ãšã³é žãé察称ãªç¡æ°Žã¯ãšã³é žãã¯ãšã³é žã®ååéç¡æ°Žç©ãããã³ãããã®çµã¿åãããããªã矀ããéžæããããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšçµæç©ããç¡æ°Žã¯ãšã³é žããªããŒãå«ããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšçµæç©ããçµå£ãŸãã¯çµèæäžçšã«è£œå€åããããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšçµæç©ããåååäœçšéãšããŠè£œå€åããããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
被éšäœã«ãããå€åããå路代è¬ã«é¢é£ããç¶æ ãåŠçœ®ããããã®ãæ²»çæå¹éã®ãåè·¯äžéäœç¡æ°Žç©ããŸãã¯è¬åŠçã«èš±å®¹ããåŸããã®å¡©ãããã¯ãããã©ãã°ãå«ãçµæç©ãæäŸããããšãå«ããåèšè¢«éšäœã«ãããå€åããå路代è¬ã«é¢é£ããç¶æ ãåŠçœ®ããããã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœããŸãã¯è¬åŠçã«èš±å®¹ããåŸããã®å¡©ãããã¯ãããã©ãã°ããã·ãã¬ãŒããïœïœïœâã¢ã³ãããŒããâã€ãœã·ãã¬ãŒããαâã±ãã°ã«ã¿ã¬ãŒããã¹ã¯ã·ããŒããããã¬ãŒãããã¬ãŒãããªããµãã¢ã»ããŒãããã«ããŒããã¢ã»ãã³ãã¢ã»ãã¢ã»ããŒããβâããããã·ããã¬ãŒããβâã±ããã³ã¿ããšãŒããããã³Î²âããããã·ãã³ã¿ããšãŒããããªã矀ããéžæããããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšãããã©ãã°ããïŒã€ãŸãã¯ãããè¶ ããããªãªãŒã«ãå«ããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšãããã©ãã°ããïŒã€ãŸãã¯ãããè¶ ããã¢ããé žãå«ããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšãããã©ãã°ããïŒã€ãŸãã¯ãããè¶ ããããªãªãŒã«ãšãïŒã€ãŸãã¯ãããè¶ ããã¢ããé žãšãå«ããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœç¡æ°Žç©ããŸãã¯è¬åŠçã«èš±å®¹ããåŸããã®å¡©ãããã¯ãããã©ãã°ããç¡æ°Žã¯ãšã³é žããŸãã¯è¬åŠçã«èš±å®¹ããåŸããã®å¡©ãããã¯ãããã©ãã°ã§ãããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšç¡æ°Žã¯ãšã³é žãã察称ãªç¡æ°Žã¯ãšã³é žãé察称ãªç¡æ°Žã¯ãšã³é žãã¯ãšã³é žã®ååéç¡æ°Žç©ãããã³ãããã®çµã¿åãããããªã矀ããéžæããããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšå€åããå路代è¬ã«é¢é£ããç¶æ ããéºäŒæ§é害ãç¥çµå€æ§é害ãããããšãã«ã®ãŒé害ãé£æ²»æ§ãŠããããããããªã³é žè¡çïŒïŒ°ïŒ¡ïŒãã¡ãã«ããã³é žè¡çïŒïŒïŒïŒ¡ïŒãé·éèèªé žé žåé害ãã¹ã¯ã·ãã«ïŒ£ïœïŒ¡ãªã¢ãŒãŒæ¬ æçããã«ãã³é žã«ã«ããã·ã©ãŒãŒæ¬ æçãããã³ã³ããªã¢åŒåžéäžå šçãã°ã«ã¿ã«é žè¡çïŒåãããã¯ïŒå ç¥çµçŸæ£ãé害ããããã¯ç¶æ ãçŒçãããã¯ç²åŽç ãçãžã¹ãããã£ãŒãããã³ã³ããªã¢ççãé«ä¹³é žè¡çãšè³åäžæ§çç¶ããã€è³ççïŒïŒïŒ¥ïŒ¬ïŒ¡ïŒ³ïŒãèµ€è²ãŒãç·ç¶ã䌎ãããªã¯ããŒãã¹ãŠãããïŒïŒïŒ¥ïŒ²ïŒ²ïŒŠïŒãããã³ã³ããªã¢é¢é£çŸæ£ãããã³ïŒ°ïŒ¯ïŒ¬ïŒ§å€ç°ã«é¢é£ããé害ãããªã矀ããéžæããããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšçµæç©ããçµå£ãŸãã¯çµèæäžçšã«è£œå€åããããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšçµæç©ããåååäœçšéãšããŠè£œå€åããããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
æ¬æ现æžã«é瀺ããã³èª¬æãããã®ã«å ããŠãæ¬çºæã®çš®ã ã®æ¹å€ããã³ãããªãå€æ°ã®å®æœåœ¢æ ããæ¬æ现æžã§å ·äœçã«åŒçšããç§åŠçæç®ããã³ç¹èš±æç®ãžã®åç §ãå«ãæ¬æ现æžã®å å®¹å šäœãããåœæ¥è ã«æããã«ãªãã§ããããããã§ã®äž»é¡ã¯ãæ¬çºæã®çš®ã ã®å®æœåœ¢æ ããã³ãã®åçç©ã®å®æœã«é©åããåŸããéèŠãªæ å ±ãäŸç€ºãããã³ã¬ã€ãã³ã¹ãå«ãã§ããã
æ¬çºæã¯ãäŸãã°ä»¥äžã®é ç®ãæäŸããã
ïŒé ç®ïŒïŒ
ïŒã€ãŸãã¯ãããè¶ ããåè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ãšã
ïŒã€ãŸãã¯ãããè¶ ããã¢ããé žãš
ãå«ããååç©ã
ïŒé ç®ïŒïŒ
åèšååç©ãã
äºãã«ååŠçã«çµåããïŒã€ãŸãã¯ãããè¶ ããåè·¯äžéäœãããã¯ãã®ãããã©ãã°ãšã
ïŒã€ãŸãã¯ãããè¶ ããã¢ããé žãš
ãå«ããé ç®ïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããåè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããã·ãã¬ãŒããïœïœïœâã¢ã³ãããŒããâã€ãœã·ãã¬ãŒããαâã±ãã°ã«ã¿ã¬ãŒããã¹ã¯ã·ããŒããããã¬ãŒãããã¬ãŒãããªããµãã¢ã»ããŒãããã«ããŒããã¢ã»ãã³ãã¢ã»ãã¢ã»ããŒããβâããããã·ããã¬ãŒããβâã±ããã³ã¿ããšãŒããããã³Î²âããããã·ãã³ã¿ããšãŒããããªã矀ããéžæããããé ç®ïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããåè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããã¹ã¯ã·ããŒãã§ãããé ç®ïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããåŒïŒïŒ©ïŒãïŒïŒ©ïŒ©ïŒãïŒïŒ©ïŒ©ïŒ©ïŒãïŒïŒ©ïŒ¶ïŒãããã³ïŒïŒ¶ïŒïŒ
ââïŒïŒ¶ïŒ
ãããªã矀ããéžæãããåŒã§è¡šãããåŒäžã
ã¯ãã»ãªã³ã§ããïŒ
ã¯ãã¹ã¯ã·ããŒãã§ããïŒ
ã¯ããã¬ãŒãã§ããïŒ
ã¯ãã¹ã¯ã·ããŒãã§ããïŒãã€
ã¯ãã»ãªã³ã§ããã
é ç®ïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããã¢ããé žããã»ãªã³ããã³ããã·ã³ãããªã矀ããéžæããããé ç®ïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããã¢ããé žããã»ãªã³ã§ãããé ç®ïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããäžéäœãããã¯ãã®ãããã©ãã°ããããªãªãŒã«ãä»ããŠçµåããŠãããé ç®ïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒ
åèšããªãªãŒã«ããã°ãªã»ããŒã«ã§ãããé ç®ïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšååç©ããåŒïŒïŒ¶ïŒ©ïŒïŒ
ã§è¡šãããåŒäžã
 ïŒ ã ïŒ ãããã³ïŒ² ïŒ ããã¹ã¯ã·ããŒãã§ããïŒ
 ïŒ ã ïŒ ãããã³ïŒ² ïŒ ããã»ãªã³ã§ããïŒãã€
 ïŒ ã ïŒ ãããã³ïŒ² ïŒ ãããããã®åŽéäžã®é žçŽ ååãä»ããŠããããã ïŒ ã ïŒ ãããã³ïŒ² ïŒ ãšçµåããŠããã
é ç®ïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
ïŒã€ãŸãã¯ãããè¶ ããåè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ãšïŒ
ïŒã€ãŸãã¯ãããè¶ ããã¢ããé žãš
ãå«ãååç©ãã被éšäœã«æäŸããããšãå«ããåèšè¢«éšäœã«ãããå€åããå路代è¬ã«é¢é£ããç¶æ ãåŠçœ®ããæ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšååç©ãã
äºãã«ååŠçã«çµåããïŒã€ãŸãã¯ãããè¶ ããåè·¯äžéäœãããã¯ãã®ãããã©ãã°ãšïŒ
ïŒã€ãŸãã¯ãããè¶ ããã¢ããé žãš
ãå«ããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããåè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããã·ãã¬ãŒããïœïœïœâã¢ã³ãããŒããâã€ãœã·ãã¬ãŒããαâã±ãã°ã«ã¿ã¬ãŒããã¹ã¯ã·ããŒããããã¬ãŒãããã¬ãŒãããªããµãã¢ã»ããŒãããã«ããŒããã¢ã»ãã³ãã¢ã»ãã¢ã»ããŒããβâããããã·ããã¬ãŒããβâã±ããã³ã¿ããšãŒããããã³Î²âããããã·ãã³ã¿ããšãŒããããªã矀ããéžæããããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããåè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããã¹ã¯ã·ããŒãã§ãããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããåŒïŒïŒ©ïŒãïŒïŒ©ïŒ©ïŒãïŒïŒ©ïŒ©ïŒ©ïŒãïŒïŒ©ïŒ¶ïŒãããã³ïŒïŒ¶ïŒïŒ
ââïŒïŒ¶ïŒ
ãããªã矀ããéžæãããåŒã§è¡šãããåŒäžã
ã¯ãã»ãªã³ã§ããïŒ
ã¯ãã¹ã¯ã·ããŒãã§ããïŒ
ã¯ããã¬ãŒãã§ããïŒ
ã¯ãã¹ã¯ã·ããŒãã§ããïŒãã€
ã¯ãã»ãªã³ã§ããã
é ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããã¢ããé žããã»ãªã³ããã³ããã·ã³ãããªã矀ããéžæããããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããã¢ããé žããã»ãªã³ã§ãããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããäžéäœãããã¯ãã®ãããã©ãã°ããããªãªãŒã«ãä»ããŠçµåããŠãããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšããªãªãŒã«ããã°ãªã»ããŒã«ã§ãããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšååç©ããåŒïŒïŒ¶ïŒ©ïŒïŒ
ã§è¡šãããåŒäžã
 ïŒ ã ïŒ ãããã³ïŒ² ïŒ ããã¹ã¯ã·ããŒãã§ããïŒ
 ïŒ ã ïŒ ãããã³ïŒ² ïŒ ããã»ãªã³ã§ããïŒãã€
 ïŒ ã ïŒ ãããã³ïŒ² ïŒ ãããããã®åŽéäžã®é žçŽ ååãä»ããŠããããã ïŒ ã ïŒ ãããã³ïŒ² ïŒ ãšçµåããŠããã
é ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
第ïŒã®ïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ãšïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ã«å ±æçµåããïŒã€ãŸãã¯ãããè¶ ãããã£ããã³ã°éšåãš
ãå«ããååç©ã
ïŒé ç®ïŒïŒïŒ
åãã£ããã³ã°éšåããç¬ç«ããŠããªãªãŒã«ãããªã矀ããéžæããããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããã·ãã¬ãŒããïœïœïœâã¢ã³ãããŒããâã€ãœã·ãã¬ãŒããαâã±ãã°ã«ã¿ã¬ãŒããã¹ã¯ã·ããŒããããã¬ãŒãããã¬ãŒãããªããµãã¢ã»ããŒãããã«ããŒããã¢ã»ãã³ãã¢ã»ãã¢ã»ããŒããβâããããã·ããã¬ãŒããβâã±ããã³ã¿ããšãŒããããã³Î²âããããã·ãã³ã¿ããšãŒããããªã矀ããéžæããããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããã¹ã¯ã·ããŒãã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ãããã£ããã³ã°éšåããã°ãªã»ããŒã«ã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
ååç©ããåèšã¹ã¯ã·ããŒãäžã®æ«ç«¯ççŽ ååãä»ããŠå ±æçµåããïŒã€ã®ã°ãªã»ããŒã«éšåãå«ããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšååç©ããåŒïŒïŒ¶ïŒ©ïŒ©ïŒãïŒïŒ¶ïŒ©ïŒ©ïŒ©ïŒãããã³ïŒïŒ©ïŒžïŒïŒ
ããéžæãããåŒã§è¡šããããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
第ïŒã®ãã£ããã³ã°éšåããã¢ããé žã§ããïŒ
第ïŒã®ãã£ããã³ã°éšåãã第ïŒã®ïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšç¬¬ïŒã®ïŒŽïŒ£ïŒ¡åè·¯äžéäœããã¹ã¯ã·ããŒãã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšç¬¬ïŒã®ãã£ããã³ã°éšåããã»ãªã³ã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšç¬¬ïŒã®ãã£ããã³ã°éšåãããã¬ãŒãã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšååç©ããåŒïŒïŒžïŒïŒ
ã§è¡šããããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
ããªãªãŒã«ãšïŒ
åèšããªãªãŒã«ã«å ±æçµåããåè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ãšïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ã«å ±æçµåããã¢ããé žãš
ãå«ããååç©ã
ïŒé ç®ïŒïŒïŒ
åèšããªãªãŒã«ããã°ãªã»ããŒã«ã§ããïŒ
åèšå ±æçµåããïŒïœïœïœïœïœïœ ïœïœïœïœïŒïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããã¹ã¯ã·ããŒãã§ããïŒ
åèšã¢ããé žããã»ãªã³ã§ããã
é ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšååç©ããåŒïŒïŒžïŒ©ïŒ©ïŒ©ïŒïŒ
ã§è¡šããããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšååç©ããåŒïŒïŒžïŒ©ïŒ¶ïŒïŒ
ã§è¡šããããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœããαâã±ãã°ã«ã¿ã¬ãŒãã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšã¢ããé žããã»ãªã³ã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšããªãªãŒã«ããã°ãªã»ããŒã«ã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšååç©ããåŒïŒïŒžïŒ¶ïŒïŒ
ã§è¡šããããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœããβâããããã·ããã¬ãŒãã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšã¢ããé žããã»ãªã³ã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšããªãªãŒã«ããã°ãªã»ããŒã«ã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšååç©ããåŒïŒïŒžïŒ¶ïŒ©ïŒïŒ
ã§è¡šããããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
ã·ãã¬ãŒããããã¯ã¯ãšã³é žããŸãã¯ãã®ãããã©ãã°ãã¢ããã°ãèªå°äœããããã¯å¡©ãšïŒ
ïŒã€ãŸãã¯ãããè¶ ããã¢ããé žãš
ãå«ããååç©ã
ïŒé ç®ïŒïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããã¢ããé žã®ãã¡å°ãªããšãïŒã€ã倩ç¶ã«ååšããã¢ããé žã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããã¢ããé žã®å šãŠã倩ç¶ã«ååšããã¢ããé žã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããã¢ããé žããã¢ã©ãã³ãã¢ã«ã®ãã³ãã¢ã¹ãã©ã®ã³ãã¢ã¹ãã©ã®ã³é žãã·ã¹ãã€ã³ãã°ã«ã¿ãã³ãã°ã«ã¿ãã³é žãã°ãªã·ã³ããã¹ããžã³ãã€ãœãã€ã·ã³ããã€ã·ã³ããªãžã³ãã¡ããªãã³ããã§ãã«ã¢ã©ãã³ããããªã³ãã»ãªã³ãã¹ã¬ãªãã³ãããªãããã¡ã³ãããã·ã³ãããªã³ãããã³ãããã®çµã¿åãããããªã矀ããéžæããããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããã¢ããé žã®ãã¡å°ãªããšãïŒã€ãã倩ç¶ã«ååšããªãã¢ããé žã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããã¢ããé žã®å šãŠã倩ç¶ã«ååšããªãã¢ããé žã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšïŒã€ãŸãã¯ãããè¶ ããã¢ããé žãã倩ç¶ã«ååšããã¢ããé žãšã倩ç¶ã«ååšããªãã¢ããé žãšã®çµã¿åããã§ãããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšååç©ããè€æ°ã®ã¢ããé žãå«ããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšååç©ããïŒã€ã®ã¢ããé žãå«ããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšååç©ããïŒã€ã®ã»ãªã³ãå«ããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
åèšååç©ããåŒïŒïŒžïŒ¶ïŒ©ïŒ©ïŒïŒ
ã§è¡šããããé ç®ïŒïŒã«èšèŒã®ååç©ã
ïŒé ç®ïŒïŒïŒ
被éšäœã«ãããå€åããå路代è¬ã«é¢é£ããç¶æ ãåŠçœ®ããããã®ãæ²»çæå¹éã®ãïŒã€ãŸãã¯ãããè¶ ããããªãªãŒã«ååã«å ±æçµåããå°ãªããšãïŒã€ã®ïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ãå«ããçµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããã·ãã¬ãŒããïœïœïœâã¢ã³ãããŒããâã€ãœã·ãã¬ãŒããαâã±ãã°ã«ã¿ã¬ãŒããã¹ã¯ã·ããŒããããã¬ãŒãããã¬ãŒãããªããµãã¢ã»ããŒãããã«ããŒããã¢ã»ãã³ãã¢ã»ãã¢ã»ããŒããβâããããã·ããã¬ãŒããβâã±ããã³ã¿ããšãŒããããã³Î²âããããã·ãã³ã¿ããšãŒããããªã矀ããéžæããããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããã·ãã¬ãŒãã§ãããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšããªãªãŒã«ããã°ãªã»ããŒã«ã§ãããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšçµæç©ããïŒã€ãŸãã¯ãããè¶ ããã°ãªã»ããŒã«ååã«å ±æçµåãããè€æ°ã®ã·ãã¬ãŒãååãå«ããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšçµæç©ããè€æ°ã®ã·ãã¬ãŒãååãå«ã¿ãåèšè€æ°ã®ã·ãã¬ãŒãååã®ãã¡å°ãªããšãïŒã€ããè€æ°ã®ã°ãªã»ããŒã«ååã«å ±æçµåããŠãããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšçµæç©ããåŒïŒžïŒ¶ïŒ©ïŒ©ïŒ©ïŒ
ã®ååç©ãå«ããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšå€åããå路代è¬ã«é¢é£ããç¶æ ããéºäŒæ§é害ãç¥çµå€æ§é害ãããããšãã«ã®ãŒé害ãé£æ²»æ§ãŠããããããããªã³é žè¡çïŒïŒ°ïŒ¡ïŒãã¡ãã«ããã³é žè¡çïŒïŒïŒïŒ¡ïŒãé·éèèªé žé žåé害ãã¹ã¯ã·ãã«ïŒ£ïœïŒ¡ãªã¢ãŒãŒæ¬ æçããã«ãã³é žã«ã«ããã·ã©ãŒãŒæ¬ æçãããã³ã³ããªã¢åŒåžéäžå šçãã°ã«ã¿ã«é žè¡çïŒåãããã¯ïŒå ç¥çµçŸæ£ãé害ããããã¯ç¶æ ãçŒçãããã¯ç²åŽç ãçãžã¹ãããã£ãŒãããã³ã³ããªã¢ççãé«ä¹³é žè¡çãšè³åäžæ§çç¶ããã€è³ççïŒïŒïŒ¥ïŒ¬ïŒ¡ïŒ³ïŒãèµ€è²ãŒãç·ç¶ã䌎ãããªã¯ããŒãã¹ãŠãããïŒïŒïŒ¥ïŒ²ïŒ²ïŒŠïŒãããã³ã³ããªã¢é¢é£çŸæ£ãããã³ïŒ°ïŒ¯ïŒ¬ïŒ§å€ç°ã«é¢é£ããé害ãããªã矀ããéžæããããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšçµæç©ããçµå£æäžçšã«è£œå€åããããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšçµæç©ããåååäœçšéãšããŠè£œå€åããããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
被éšäœã«ãããå€åããå路代è¬ã«é¢é£ããç¶æ ãåŠçœ®ããããã®ãæ²»çæå¹éã®ãïŒã€ãŸãã¯ãããè¶ ããããªãªãŒã«ååã«å ±æçµåããå°ãªããšãïŒã€ã®ïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ãå«ãçµæç©ãæäŸããããšãå«ããåèšè¢«éšäœã«ãããå€åããå路代è¬ã«é¢é£ããç¶æ ãåŠçœ®ããããã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããã·ãã¬ãŒããïœïœïœâã¢ã³ãããŒããâã€ãœã·ãã¬ãŒããαâã±ãã°ã«ã¿ã¬ãŒããã¹ã¯ã·ããŒããããã¬ãŒãããã¬ãŒãããªããµãã¢ã»ããŒãããã«ããŒããã¢ã»ãã³ãã¢ã»ãã¢ã»ããŒããβâããããã·ããã¬ãŒããβâã±ããã³ã¿ããšãŒããããã³Î²âããããã·ãã³ã¿ããšãŒããããªã矀ããéžæããããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããã·ãã¬ãŒãã§ãããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšããªãªãŒã«ããã°ãªã»ããŒã«ã§ãããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšçµæç©ããïŒã€ãŸãã¯ãããè¶ ããã°ãªã»ããŒã«ååã«å ±æçµåãããè€æ°ã®ã·ãã¬ãŒãååãå«ããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšçµæç©ããè€æ°ã®ã·ãã¬ãŒãååãå«ã¿ãåèšè€æ°ã®ã·ãã¬ãŒãååã®ãã¡å°ãªããšãïŒã€ããè€æ°ã®ã°ãªã»ããŒã«ååã«å ±æçµåããŠãããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšçµæç©ããåŒïŒžïŒ¶ïŒ©ïŒ©ïŒ©ïŒ
ã®ååç©ãå«ããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšå€åããå路代è¬ã«é¢é£ããç¶æ ããéºäŒæ§é害ãç¥çµå€æ§é害ãããããšãã«ã®ãŒé害ãé£æ²»æ§ãŠããããããããªã³é žè¡çïŒïŒ°ïŒ¡ïŒãã¡ãã«ããã³é žè¡çïŒïŒïŒïŒ¡ïŒãé·éèèªé žé žåé害ãã¹ã¯ã·ãã«ïŒ£ïœïŒ¡ãªã¢ãŒãŒæ¬ æçããã«ãã³é žã«ã«ããã·ã©ãŒãŒæ¬ æçãããã³ã³ããªã¢åŒåžéäžå šçãã°ã«ã¿ã«é žè¡çïŒåãããã¯ïŒå ç¥çµçŸæ£ãé害ããããã¯ç¶æ ãçŒçãããã¯ç²åŽç ãçãžã¹ãããã£ãŒãããã³ã³ããªã¢ççãé«ä¹³é žè¡çãšè³åäžæ§çç¶ããã€è³ççïŒïŒïŒ¥ïŒ¬ïŒ¡ïŒ³ïŒãèµ€è²ãŒãç·ç¶ã䌎ãããªã¯ããŒãã¹ãŠãããïŒïŒïŒ¥ïŒ²ïŒ²ïŒŠïŒãããã³ã³ããªã¢é¢é£çŸæ£ãããã³ïŒ°ïŒ¯ïŒ¬ïŒ§å€ç°ã«é¢é£ããé害ãããªã矀ããéžæããããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšçµæç©ããçµå£æäžçšã«è£œå€åããããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšçµæç©ããåååäœçšéãšããŠè£œå€åããããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
被éšäœã«ãããå€åããå路代è¬ã«é¢é£ããç¶æ ãåŠçœ®ããããã®ãæ²»çæå¹éã®ãåè·¯äžéäœç¡æ°Žç©ãããã¯ããªããŒããŸãã¯è¬åŠçã«èš±å®¹ããåŸããã®å¡©ãããã¯ãããã©ãã°ãå«ããçµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœãããã¯ããªããŒããŸãã¯è¬åŠçã«èš±å®¹ããåŸããã®å¡©ãããã¯ãããã©ãã°ããã·ãã¬ãŒããïœïœïœâã¢ã³ãããŒããâã€ãœã·ãã¬ãŒããαâã±ãã°ã«ã¿ã¬ãŒããã¹ã¯ã·ããŒããããã¬ãŒãããã¬ãŒãããªããµãã¢ã»ããŒãããã«ããŒããã¢ã»ãã³ãã¢ã»ãã¢ã»ããŒããβâããããã·ããã¬ãŒããβâã±ããã³ã¿ããšãŒããããã³Î²âããããã·ãã³ã¿ããšãŒããããªã矀ããéžæããããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšãããã©ãã°ããïŒã€ãŸãã¯ãããè¶ ããããªãªãŒã«ãå«ããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšãããã©ãã°ããïŒã€ãŸãã¯ãããè¶ ããã¢ããé žãå«ããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšãããã©ãã°ããïŒã€ãŸãã¯ãããè¶ ããããªãªãŒã«ãšãïŒã€ãŸãã¯ãããè¶ ããã¢ããé žãšãå«ããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœç¡æ°Žç©ãããã¯ããªããŒããŸãã¯è¬åŠçã«èš±å®¹ããåŸããã®å¡©ãããã¯ãããã©ãã°ããç¡æ°Žã¯ãšã³é žãããã¯ããªããŒããŸãã¯è¬åŠçã«èš±å®¹ããåŸããã®å¡©ãããã¯ãããã©ãã°ã§ãããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšç¡æ°Žã¯ãšã³é žãã察称ãªç¡æ°Žã¯ãšã³é žãé察称ãªç¡æ°Žã¯ãšã³é žãã¯ãšã³é žã®ååéç¡æ°Žç©ãããã³ãããã®çµã¿åãããããªã矀ããéžæããããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšçµæç©ããç¡æ°Žã¯ãšã³é žããªããŒãå«ããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšçµæç©ããçµå£ãŸãã¯çµèæäžçšã«è£œå€åããããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
åèšçµæç©ããåååäœçšéãšããŠè£œå€åããããé ç®ïŒïŒã«èšèŒã®çµæç©ã
ïŒé ç®ïŒïŒïŒ
被éšäœã«ãããå€åããå路代è¬ã«é¢é£ããç¶æ ãåŠçœ®ããããã®ãæ²»çæå¹éã®ãåè·¯äžéäœç¡æ°Žç©ããŸãã¯è¬åŠçã«èš±å®¹ããåŸããã®å¡©ãããã¯ãããã©ãã°ãå«ãçµæç©ãæäŸããããšãå«ããåèšè¢«éšäœã«ãããå€åããå路代è¬ã«é¢é£ããç¶æ ãåŠçœ®ããããã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœããŸãã¯è¬åŠçã«èš±å®¹ããåŸããã®å¡©ãããã¯ãããã©ãã°ããã·ãã¬ãŒããïœïœïœâã¢ã³ãããŒããâã€ãœã·ãã¬ãŒããαâã±ãã°ã«ã¿ã¬ãŒããã¹ã¯ã·ããŒããããã¬ãŒãããã¬ãŒãããªããµãã¢ã»ããŒãããã«ããŒããã¢ã»ãã³ãã¢ã»ãã¢ã»ããŒããβâããããã·ããã¬ãŒããβâã±ããã³ã¿ããšãŒããããã³Î²âããããã·ãã³ã¿ããšãŒããããªã矀ããéžæããããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšãããã©ãã°ããïŒã€ãŸãã¯ãããè¶ ããããªãªãŒã«ãå«ããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšãããã©ãã°ããïŒã€ãŸãã¯ãããè¶ ããã¢ããé žãå«ããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšãããã©ãã°ããïŒã€ãŸãã¯ãããè¶ ããããªãªãŒã«ãšãïŒã€ãŸãã¯ãããè¶ ããã¢ããé žãšãå«ããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœç¡æ°Žç©ããŸãã¯è¬åŠçã«èš±å®¹ããåŸããã®å¡©ãããã¯ãããã©ãã°ããç¡æ°Žã¯ãšã³é žããŸãã¯è¬åŠçã«èš±å®¹ããåŸããã®å¡©ãããã¯ãããã©ãã°ã§ãããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšç¡æ°Žã¯ãšã³é žãã察称ãªç¡æ°Žã¯ãšã³é žãé察称ãªç¡æ°Žã¯ãšã³é žãã¯ãšã³é žã®ååéç¡æ°Žç©ãããã³ãããã®çµã¿åãããããªã矀ããéžæããããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšå€åããå路代è¬ã«é¢é£ããç¶æ ããéºäŒæ§é害ãç¥çµå€æ§é害ãããããšãã«ã®ãŒé害ãé£æ²»æ§ãŠããããããããªã³é žè¡çïŒïŒ°ïŒ¡ïŒãã¡ãã«ããã³é žè¡çïŒïŒïŒïŒ¡ïŒãé·éèèªé žé žåé害ãã¹ã¯ã·ãã«ïŒ£ïœïŒ¡ãªã¢ãŒãŒæ¬ æçããã«ãã³é žã«ã«ããã·ã©ãŒãŒæ¬ æçãããã³ã³ããªã¢åŒåžéäžå šçãã°ã«ã¿ã«é žè¡çïŒåãããã¯ïŒå ç¥çµçŸæ£ãé害ããããã¯ç¶æ ãçŒçãããã¯ç²åŽç ãçãžã¹ãããã£ãŒãããã³ã³ããªã¢ççãé«ä¹³é žè¡çãšè³åäžæ§çç¶ããã€è³ççïŒïŒïŒ¥ïŒ¬ïŒ¡ïŒ³ïŒãèµ€è²ãŒãç·ç¶ã䌎ãããªã¯ããŒãã¹ãŠãããïŒïŒïŒ¥ïŒ²ïŒ²ïŒŠïŒãããã³ã³ããªã¢é¢é£çŸæ£ãããã³ïŒ°ïŒ¯ïŒ¬ïŒ§å€ç°ã«é¢é£ããé害ãããªã矀ããéžæããããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšçµæç©ããçµå£ãŸãã¯çµèæäžçšã«è£œå€åããããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
ïŒé ç®ïŒïŒïŒ
åèšçµæç©ããåååäœçšéãšããŠè£œå€åããããé ç®ïŒïŒã«èšèŒã®æ¹æ³ã
Claims (15)
- ïŒã€ãŸãã¯ãããè¶ ããåè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ãšã
ïŒã€ãŸãã¯ãããè¶ ããã¢ããé žãš
ãå«ããååç©ã - åèšååç©ãã
äºãã«ååŠçã«çµåããïŒã€ãŸãã¯ãããè¶ ããåè·¯äžéäœãããã¯ãã®ãããã©ãã°ãšã
ïŒã€ãŸãã¯ãããè¶ ããã¢ããé žãš
ãå«ããè«æ±é ïŒã«èšèŒã®ååç©ã - åèšïŒã€ãŸãã¯ãããè¶ ããåè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããã·ãã¬ãŒããïœïœïœâã¢ã³ãããŒããâã€ãœã·ãã¬ãŒããαâã±ãã°ã«ã¿ã¬ãŒããã¹ã¯ã·ããŒããããã¬ãŒãããã¬ãŒãããªããµãã¢ã»ããŒãããã«ããŒããã¢ã»ãã³ãã¢ã»ãã¢ã»ããŒããβâããããã·ããã¬ãŒããβâã±ããã³ã¿ããšãŒããããã³Î²âããããã·ãã³ã¿ããšãŒããããªã矀ããéžæããããè«æ±é ïŒã«èšèŒã®ååç©ã
- åèšïŒã€ãŸãã¯ãããè¶ ããåè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããã¹ã¯ã·ããŒãã§ãããè«æ±é ïŒã«èšèŒã®ååç©ã
- åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããåŒïŒïŒ©ïŒãïŒïŒ©ïŒ©ïŒãïŒïŒ©ïŒ©ïŒ©ïŒãïŒïŒ©ïŒ¶ïŒãããã³ïŒïŒ¶ïŒïŒ
ââïŒïŒ¶ïŒ
ãããªã矀ããéžæãããåŒã§è¡šãããåŒäžã
ã¯ãã»ãªã³ã§ããïŒ
ã¯ãã¹ã¯ã·ããŒãã§ããïŒ
ã¯ããã¬ãŒãã§ããïŒ
ã¯ãã¹ã¯ã·ããŒãã§ããïŒãã€
ã¯ãã»ãªã³ã§ããã
è«æ±é ïŒã«èšèŒã®ååç©ã - åèšïŒã€ãŸãã¯ãããè¶ ããã¢ããé žããã»ãªã³ããã³ããã·ã³ãããªã矀ããéžæããããè«æ±é ïŒã«èšèŒã®ååç©ã
- åèšïŒã€ãŸãã¯ãããè¶ ããã¢ããé žããã»ãªã³ã§ãããè«æ±é ïŒã«èšèŒã®ååç©ã
- åèšïŒã€ãŸãã¯ãããè¶ ããäžéäœãããã¯ãã®ãããã©ãã°ããããªãªãŒã«ãä»ããŠçµåããŠãããè«æ±é ïŒã«èšèŒã®ååç©ã
- åèšããªãªãŒã«ããã°ãªã»ããŒã«ã§ãããè«æ±é ïŒã«èšèŒã®ååç©ã
- åèšååç©ããåŒïŒïŒ¶ïŒ©ïŒïŒ
ïŒãïŒãããã³ïŒ²ïŒããã¹ã¯ã·ããŒãã§ããïŒ
ïŒãïŒãããã³ïŒ²ïŒããã»ãªã³ã§ããïŒãã€
ïŒãïŒãããã³ïŒ²ïŒãããããã®åŽéäžã®é žçŽ ååãä»ããŠãããããïŒãïŒãããã³ïŒ²ïŒãšçµåããŠããã
è«æ±é ïŒã«èšèŒã®ååç©ã - ïŒã€ãŸãã¯ãããè¶ ããåè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ãšïŒ
ïŒã€ãŸãã¯ãããè¶ ããã¢ããé žãš
ãå«ãååç©ãå«ãçµæç©ã§ãã£ãŠã被éšäœã«ãããå€åããå路代è¬ã«é¢é£ããç¶æ ãåŠçœ®ããããã®çµæç©ã - åèšååç©ãã
äºãã«ååŠçã«çµåããïŒã€ãŸãã¯ãããè¶ ããåè·¯äžéäœãããã¯ãã®ãããã©ãã°ãšïŒ
ïŒã€ãŸãã¯ãããè¶ ããã¢ããé žãš
ãå«ããè«æ±é ïŒïŒã«èšèŒã®çµæç©ã - åèšïŒã€ãŸãã¯ãããè¶ ããåè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããã·ãã¬ãŒããïœïœïœâã¢ã³ãããŒããâã€ãœã·ãã¬ãŒããαâã±ãã°ã«ã¿ã¬ãŒããã¹ã¯ã·ããŒããããã¬ãŒãããã¬ãŒãããªããµãã¢ã»ããŒãããã«ããŒããã¢ã»ãã³ãã¢ã»ãã¢ã»ããŒããβâããããã·ããã¬ãŒããβâã±ããã³ã¿ããšãŒããããã³Î²âããããã·ãã³ã¿ããšãŒããããªã矀ããéžæããããè«æ±é ïŒïŒã«èšèŒã®çµæç©ã
- åèšïŒã€ãŸãã¯ãããè¶ ããåè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããã¹ã¯ã·ããŒãã§ãããè«æ±é ïŒïŒã«èšèŒã®çµæç©ã
- åèšïŒŽïŒ£ïŒ¡åè·¯äžéäœãŸãã¯ãã®ãããã©ãã°ããåŒïŒïŒ©ïŒãïŒïŒ©ïŒ©ïŒãïŒïŒ©ïŒ©ïŒ©ïŒãïŒïŒ©ïŒ¶ïŒãããã³ïŒïŒ¶ïŒïŒ
ââïŒïŒ¶ïŒ
ãããªã矀ããéžæãããåŒã§è¡šãããåŒäžã
ã¯ãã»ãªã³ã§ããïŒ
ã¯ãã¹ã¯ã·ããŒãã§ããïŒ
ã¯ããã¬ãŒãã§ããïŒ
ã¯ãã¹ã¯ã·ããŒãã§ããïŒãã€
ã¯ãã»ãªã³ã§ããã
è«æ±é ïŒïŒã«èšèŒã®çµæç©ã
Applications Claiming Priority (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762536318P | 2017-07-24 | 2017-07-24 | |
US62/536,318 | 2017-07-24 | ||
US201762547547P | 2017-08-18 | 2017-08-18 | |
US62/547,547 | 2017-08-18 | ||
US201862710357P | 2018-02-16 | 2018-02-16 | |
US62/710,357 | 2018-02-16 | ||
US201862650395P | 2018-03-30 | 2018-03-30 | |
US62/650,395 | 2018-03-30 | ||
US201862662014P | 2018-04-24 | 2018-04-24 | |
US62/662,014 | 2018-04-24 | ||
US201862667893P | 2018-05-07 | 2018-05-07 | |
US62/667,893 | 2018-05-07 | ||
US201862677940P | 2018-05-30 | 2018-05-30 | |
US62/677,940 | 2018-05-30 | ||
PCT/US2018/043487 WO2019023231A1 (en) | 2017-07-24 | 2018-07-24 | COMPOSITIONS AND METHODS FOR TREATING STATES ASSOCIATED WITH MODIFIED TCA CYCLE METABOLISM |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2020528891A JP2020528891A (ja) | 2020-10-01 |
JP2020528891A5 true JP2020528891A5 (ja) | 2021-07-26 |
Family
ID=65041397
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020503266A Pending JP2020528891A (ja) | 2017-07-24 | 2018-07-24 | å€åããïœïœïœå路代è¬ã«é¢é£ããç¶æ ãåŠçœ®ããããã®çµæç©ããã³æ¹æ³ |
Country Status (9)
Country | Link |
---|---|
US (1) | US20200140375A1 (ja) |
EP (1) | EP3658135A4 (ja) |
JP (1) | JP2020528891A (ja) |
KR (1) | KR20200031146A (ja) |
CN (1) | CN111201018A (ja) |
AU (1) | AU2018307945A1 (ja) |
CA (1) | CA3070233A1 (ja) |
IL (1) | IL272210A (ja) |
WO (1) | WO2019023231A1 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2022504584A (ja) * | 2018-10-11 | 2022-01-13 | ã€ã³ããªã¢ ãã¡ãŒãã·ã¥ãŒãã£ã«ã«ãºïŒ ã€ã³ã³ãŒãã¬ã€ããã | ïœïœåè·¯äžéäœããã³ãã®äœ¿çšæ¹æ³ |
WO2020163188A1 (en) * | 2019-02-08 | 2020-08-13 | Imbria Pharmaceuticals, Inc. | Compositions containing n-acetylcysteine conjugated to a tca cycle intermediate |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3274225B2 (ja) * | 1992-06-03 | 2002-04-15 | å¯å£«åçãã€ã«ã æ ªåŒäŒç€Ÿ | ã¢ããé žèªå°äœåã³ãã®çšé |
JPH0782225A (ja) * | 1993-09-14 | 1995-03-28 | Fuji Photo Film Co Ltd | ã¢ããé žèªå°äœåã³ãã®çšé |
US5820881A (en) * | 1995-04-28 | 1998-10-13 | Emisphere Technologies, Inc. | Microspheres of diamide-dicarboxylic acids |
US6835750B1 (en) * | 2000-05-01 | 2004-12-28 | Accera, Inc. | Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II |
US20120027859A1 (en) * | 2008-10-15 | 2012-02-02 | Turnell William G | Biodegradable Proline-Based Polymers |
CN103739576B (zh) * | 2014-01-24 | 2016-08-24 | å京æ®çåææèµæéå ¬åž | äžç§æç æ¯ç©¿å¿è²å é ¯è¡çç©åå ¶å¶å€æ¹æ³ååºçš |
US10583084B2 (en) * | 2014-06-26 | 2020-03-10 | Ramot At Tel-Aviv University Ltd. | Liposomal formulations for delivery of nucleic acids |
CN106748890B (zh) * | 2016-11-24 | 2018-12-14 | å京工äžå€§åŠ | äžç§l-çæ°šé žç¥çé žçåå ¶å¶å€æ¹æ³ååºçš |
-
2018
- 2018-07-24 AU AU2018307945A patent/AU2018307945A1/en not_active Abandoned
- 2018-07-24 EP EP18837220.5A patent/EP3658135A4/en not_active Withdrawn
- 2018-07-24 CN CN201880062002.XA patent/CN111201018A/zh active Pending
- 2018-07-24 WO PCT/US2018/043487 patent/WO2019023231A1/en unknown
- 2018-07-24 US US16/324,406 patent/US20200140375A1/en not_active Abandoned
- 2018-07-24 KR KR1020207004786A patent/KR20200031146A/ko not_active Application Discontinuation
- 2018-07-24 JP JP2020503266A patent/JP2020528891A/ja active Pending
- 2018-07-24 CA CA3070233A patent/CA3070233A1/en active Pending
-
2020
- 2020-01-23 IL IL272210A patent/IL272210A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2020528891A5 (ja) | ||
JP2020073472A5 (ja) | ||
JP5249016B2 (ja) | ã¿ããµã³é¡ã®é«ååçµåäœ | |
ES2621306T3 (es) | Profármacos de metilfenidato, procesos para la obtención y uso de los mismos | |
RU2010106877A (ru) | ÐОпепÑОЎМÑе пÑПлекаÑÑÑва О ÐžÑ Ð¿ÑОЌеМеМОе | |
JP2013503862A5 (ja) | ||
RU2012108874A (ru) | ÐПЌпПзОÑОО, ÑПЎеÑжаÑОе ÑаÑÑеплÑеЌÑе ÑеÑЌеМÑаЌО ПпОПОЎМÑе пÑПлекаÑÑÑва Ñ ÐŒÐŸÐŽÐžÑОÑОÑПваММÑÐŒ кеÑПМПЌ О ÐžÑ ÐŽÐŸÐ¿ÐŸÐ»ÐœÐžÑелÑÐœÑе ОМгОбОÑПÑÑ | |
KR970042553A (ko) | ìº íí í ì ì ë첎 | |
JP7130818B2 (ja) | ç¹ç°çççåææ§ã¡ãã£ãšãŒã¿ãŒã®å¡©ã«é¢é£ããçµæç©åã³æ¹æ³ | |
JP2013537195A5 (ja) | çŸæ£ãæ²»çããããã®å»è¬ååã³åå»è¬åãå«ãããã | |
JPH08509490A (ja) | ïŒâã¢ããâãã«ãªããã³ã¶ããããã³çŽ°èæ¯æ§ãããã©ãã°ãšããŠã®ãããã®äœ¿çš | |
WO2006103274A8 (fr) | Inhibiteurs d'age | |
WO2019038637A1 (en) | FORMS OF CRYSTALLINE SALT OF LEVODOPA AMIDE AND METHODS OF MAKING AND USING THEM | |
NL8203167A (nl) | Nieuwe aminozuurisomeren, werkwijze voor de bereiding daarvan, alsmede hun medische toepassing. | |
JP2020507567A5 (ja) | ||
JP2018536645A5 (ja) | ||
KR890701545A (ko) | 걎ì ì¹ë£ë¥Œ ìí ì ìœíì ì¡°ì±ë¬Œ | |
JP2010540448A5 (ja) | ||
CA3070233A1 (en) | Compositions and methods for treating conditions associated with altered tca cycle metabolism | |
JP2717656B2 (ja) | çœéèªå°äœããã³ãããçšããç现èå¢æ®çŠæ¢çšè¬å€çµæç© | |
JP2017036455A5 (ja) | ||
JP2012520274A (ja) | å¿ é èèªé žååç© | |
WO2023129956A2 (en) | Dimethyltryptamine analogues as nitric oxide delivery drugs | |
JP2017160125A (ja) | æ žé žä»£è¬æ®æå€ãçµåããããªã¢ããé žèªå°äœã | |
KR20220103918A (ko) | ë 볎ëí ìë¯žë žì° ì í©ì²Žë¥Œ í¬íšíë ì¡ì²Ž ì¡°ì±ë¬Œ ë° ê·žì ì©ë |